TEVA-CLONIDINE 0.025 MG
CLONIDINE HYDROCHLORIDE : 0.025 MG · DIN 02304163 · TEVA CANADA LIMITED
Health Canada status: MARKETED
What is TEVA-CLONIDINE?
TEVA-CLONIDINE 0.025 MG contains CLONIDINE HYDROCHLORIDE : 0.025 MG. It is listed in the Health Canada Drug Product Database under DIN 02304163, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 17-Jan-2014. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TEVA-CLONIDINE used for?
Relief of menopausal flushing in patients for whom hormonal replacement therapy is either unnecessary or not desirable.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02304163 |
|---|---|
| Brand name | TEVA-CLONIDINE |
| Generic / active ingredient | CLONIDINE HYDROCHLORIDE : 0.025 MG |
| Manufacturer | TEVA CANADA LIMITED |
| Strength | 0.025 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C02AC01 CLONIDINE |
| AHFS class | 24:08.16 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 17-Jan-2014 |
| Original market date | 2008-06-26 00:00:00 |
How is it administered?
Recommended dose: 0.05 mg twice daily. If no remission after 2-4 weeks, discontinue. Discontinue gradually over 2-4 days. Tablets should be swallowed whole with water.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at controlled room temperature (15°C - 30°C). Protect from moisture.
How is it supplied?
Bottles of 100 and 500 tablets.
Contraindications
Hypersensitivity to clonidine; severe bradyarrhythmia (sick sinus syndrome, 2nd/3rd degree AV block); sinus node impairment; rare hereditary galactose intolerance.
Warnings and precautions
Do not discontinue abruptly (risk of catecholamine excess). May cause sedation (caution driving). Can lower blood pressure/heart rate; use caution in cardiovascular disease or renal failure.
What can be used instead?
Other Canadian products sharing ATC code C02AC01 CLONIDINE. 14 of 31 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CLONIDINE | 0.025 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02540061 |
| CLONIDINE | 0.1 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02538490 |
| CLONIDINE | 0.2 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02538504 |
| JAMP CLONIDINE | 0.025 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02528207 |
| MAR-CLONIDINE | 0.025 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02524198 |
| MINT-CLONIDINE | 0.025 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02534738 |
| MINT-CLONIDINE | 0.1 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02462192 |
| MINT-CLONIDINE | 0.2 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02462206 |
| SANDOZ CLONIDINE | 0.025 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02516217 |
| SANDOZ CLONIDINE | 0.1 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02515784 |
Who else supplies CLONIDINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CLONIDINE appears in 41 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.